A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
Clinical trial NCT03216226 · COMPLETED
Trial details
- NCT number
- NCT03216226
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2018-02-13
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.